Panacea Index Logo

Command Palette

Search for a command to run...

Omega-3 fatty acids and lipoprotein associated phospholipase A(2) in healthy older adult males and females.

European journal of nutrition
April 1, 2011
T L Nelson et al. (3 authors)
Journal ArticleRandomized Controlled TrialResearch Support, U.S. Gov't, Non-P.H.S.Human StudyClinical
Study Details

Study Goal

The researchers aimed to determine if an 8-week diet supplemented with flaxseed oil (ALA) would alter Lp-PLA(2) levels, an inflammatory marker linked to cardiovascular disease, in healthy adults aged 50+.

Results Summary

The study found no significant changes in Lp-PLA(2) mass or activity after flaxseed oil supplementation, though changes in oxidized LDL were associated with Lp-PLA(2) mass.

Population

Healthy adults aged 50+ (~75% female, average age 61 years).

Effective Dosage

~11 g/day of flaxseed oil capsules.

Duration

8 weeks.

Interactions

None mentioned.

Extracted Claims (5)
InterventionDirectionEndpointPopulationDosageImpactClaim #
8-week isocaloric diet supplemented with eicosapentaenoic acid (EPA) and docosahexaenoic (DHA) in the form of fish oil
no change
Lp-PLA(2) activity or mass
healthy adults ages 50 years and older
no significant changes
did not influence
#1
8-week isocaloric diet supplemented with α-linolenic acid (ALA) in the form of flaxseed oil
no change
Lp-PLA(2) activity or mass
healthy adults ages 50 years and older
no significant changes
did not influence
#2
control group consuming olive oil capsules
no change
Lp-PLA(2) mass or activity
healthy adults ages 50 years and older
no significant changes
did not find any significant changes
#3
-
neutral
Lp-PLA(2) mass
-
r = 0.37, p < 0.01
was associated with
#4
omega-3 fatty acids
no change
Lp-PLA(2) activity or mass
older adults
-
did not influence
#5
Abstract

PURPOSE: Lipoprotein associated phospholipase A(2) (Lp-PLA(2)) is a novel inflammatory factor that has been independently associated with stroke and cardiovascular disease (CVD). Omega-3 fats have been implicated in reducing inflammation associated with CVD. The aim of this study was to determine if an 8-week isocaloric diet supplemented with eicosapentaenoic acid (EPA) and docosahexaenoic (DHA) in the form of fish oil or α-linolenic acid (ALA) in the form of flaxseed oil would alter Lp-PLA(2) among healthy adults ages 50 years and older. METHODS: Fifty-nine healthy adults (~75% female, average age 61 years) were randomized to one of three groups with equal amounts of total fat intake. All capsules contained ~1 g of fat. The control group (n = 19) consumed olive oil capsules (~11 g/day); the ALA group (n = 20) consumed flaxseed oil capsules (~11 g/day) and the EPA/DHA group (n = 20) consumed fish oil capsules (~2 g/day + 9 g/day of olive oil). Fasting blood samples were obtained before and after the 8-week intervention for determination of Lp-PLA(2) mass and activity as well as lipid values. RESULTS: We did not find any significant changes in Lp-PLA(2) mass or activity after the intervention in any of the groups; however, change in oxidized LDL was associated with change in Lp-PLA(2) mass (r = 0.37, p < 0.01). CONCLUSION: Supplementing the diet with omega-3 fatty acids for 8-weeks did not influence Lp-PLA(2) activity or mass among older adults; altering oxidized LDL may be necessary to see changes in Lp-PLA(2) levels.

Medical Subject Headings (MeSH)
1-Alkyl-2-acetylglycerophosphocholine EsteraseAgedDietDietary SupplementsDocosahexaenoic AcidsEicosapentaenoic AcidFemaleFish OilsHumansLinseed OilLipoproteins, LDLMaleMiddle AgedOlive OilPlant OilsSingle-Blind MethodSurveys and Questionnairesalpha-Linolenic Acid
Study Links
Quality Scores
Safety90
Efficacy30/10
Quality80/10
Citation Metrics
Total Citations24
Citations/Year1.7
Relative Citation Ratio0.88
NIH Percentile45.6%
Research Impact Scores
APT Score0.75
Weight Score1.35
Normalized Score0.64
Related Supplements
Omega-3 fatty acids and lipoprotein associated phospholipase... | Panacea Index